Preliminary report on gemcitabine (G) — Ifosfamide (I) — Cisplatin (P) phase I/II trial in patients with advanced non small cell lung cancer (NSCLC) von Bourgeois, H., Lemerre, D., Chicoyneau, V., Paitry, T., Chieze, S., Fruge, F., Boita, F., Meurice, J.C., Daban, A.

Volltext